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Protein Prenylation
• Post-translational 
modification
• Occurs in most eukaryotic 
cells
• ~2% of mammalian 
proteome is prenylated
• Necessary for membrane 
targeting and proper 
functioning
• Ras subfamily: Protein 
subfamily of small GTPases 
involved in cell signaling
• Mutated Ras: responsible 
for ~30% of cancers
Scope of the Project
Synthetic Route
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• Both of C15-alkyne and the 
proposed 7-substituted analog 
have an alkyne group, which 
allows for tagging of peptides 
via “click-chemistry”
• Different analogs may 
farnesylate some Caax-box 
peptide sequences but not 
others, making use of multiple 
analogs advantageous in 
attempts at identifying the 
prenylated proteome
